Magnetic resonance imaging in spondyloarthritis

Current Opinion in Rheumatology

Volumn 22, Issue 4, 2010, Pages 381-387

  Marzo Ortega, Helena ^a   McGonagle, Dennis ^a   Bennett, Alexander N ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Defence Medical Rehabilitation Centre   (United Kingdom)

Author keywords

Imaging; MRI; Spondyloarthritis

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR INHIBITOR;

BACKACHE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; LUMBAR SPINE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REVIEW; SACROILIAC JOINT; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY; WHOLE BODY MRI;

DISEASE PROGRESSION; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; SACROILIAC JOINT; SPINE; SPONDYLARTHRITIS;

EID: 77953479947     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328339381e     Document Type: Review

References (46)

1. Marzo-Ortega H, McGonagle D, O'Connor P, et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain: relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 2009; 68:1721-1727.
2. Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009; 60:946-954.
3. Haibel H, RudwaleitM, Listing J, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 2008; 58:1981-1991.
4. Rudwaleit M, van der Heijde D, Landewe R, et al. The development of assessment of spondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777-783.
5. Rudwaleit M, Jurik AG, Hermann KG, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68:1520-1527.
6. Bennett AN, Rehman A, Hensor EM, et al. Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis. Arthritis Rheum 2009; 60:1331-1341.
7. Bennett AN, Rehman A, Hensor EM, et al. The fatty Romanus lesion: a noninflammatory spinal MRI lesion specific for axial spondyloarthropathy. Ann Rheum Dis 2009 [Epub ahead of print]
8. Maksymowych WP, Chiowchanwisawakit P, ClareT, et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009; 60:93-102.
9. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of Spondylo-Arthritis international Society (ASAS) handbook: a guide to assess spondy loarthritis. Ann Rheum Dis 2009; 68 (Suppl 2):ii1-ii44.
10. Taniguchi Y, Kumon Y, Arii K, et al. Clinical implication of 18F-fluorodeox-yglucose PET/CT in monitoring disease activity in spondyloarthritis. Rheumatology 2010; 49:829.
11. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year follow-up. J Rheumatol 1988; 15:1109-1114.
12. Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23:61-66.
13. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994; 37:1039-1045.
14. Puhakka KB, Jurik AG, Schiottz-Christensen B, et al. Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy: abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 2004; 43:234-237.
15. Heuft-Dorenbosch L, Weijers R, Landewe R, et al. Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: interreader reliability and prevalence of abnormalities. Arthritis Res Ther 2006; 8:R11.
16. Barkham N KH, Coates LCC, O'Connor PJ, et al. Clinical response and time to active disease following infliximab therapy in patients with HLA-B27 positive very early ankylosing spondylitis [abstract (OP-0016)]. Ann Rheum Dis 2009; 68:73.
17. Rudwaleit M, Schwarzlose S, Hilgert ES, et al. MRI in predicting a major clinical response to antitumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008; 67:1276-1281.
18. Baraliakos X, Hermann KG, Landewe R, et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 2005; 64:1141-1144.
19. Hermann KG, Landewe RB, Braun J, van der Heijde DM. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? J Rheumatol 2005; 32:2056-2060.
20. Madsen KB, Egund N, Jurik AG. Grading of inflammatory disease activity in the sacroiliac joints with magnetic resonance imaging: comparison between short-tau inversion recovery and gadolinium contrast-enhanced sequences. J Rheumatol 2010; 37:393-400.
21. Broome DR, Girguis MS, Baron PW, et al. Gadodiamide-associated nephro-genic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007; 188:586-592.
22. Geijer M, Gadeholt Gothlin G, Gothlin JH. The validity of the New York radiological grading criteria in diagnosing sacroiliitis by computed tomography. Acta Radiol 2009; 50:664-673.
23. Van der Linden S, HA V, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York Criteria. Arthritis Rheum 1984; 27:361-368.
24. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthro-pathy Study Group preliminary criteria for the classification of spondylarthro-pathy. Arthritis Rheum 1991; 34:1218-1227.
25. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylar-thropathies. Rev Rhum Mal Osteoartic 1990; 57:85-89.
26. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717-727.
27. Marzo-Ortega H, O'Connor P, Emery P, McGonagle D. Sacroiliac joint biopsies in early sacroiliitis. Rheumatology (Oxford) 2007; 46:1210-1211.
28. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38:499-505.
29. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58:3413-3418.
30. Bennett AN, Marzo-Ortega H, Rehman A, Emery P, McGonagle D. The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy. Rheumatology 2010; 49:426-432.
31. Lambert RGW PS, Maksymowych WP, Chiowchanwisawakit P, Østegaard M.S. Active inflammatory lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis: definitions, assessment system, and reference image set J Rheumatol 2009; 36:3-17. [Epub ahead of print]
32. Østegaard M MW, Pedersen SJ, Chiowchanwisawakit P, Lambert RGW. Structural lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis: definitions, assessment system, and reference image set. J Rheumatol 2009; 36:18-34. [Epub ahead of print]
33. Maksymowych WP CS, Dhillon SS, Conner-Spady B, Lambert RGW. Systematic assessment of inflammation by magnetic resonance imaging in the posterior elements of the spine in ankylosing spondylitis. Arthritis Care Res 2010; 62:4-10. [Epub ahead of print]
34. Treitl M, Korner M, Becker-Gaab C, et al. Magnetic resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondy-litis. J Rheumatol 2008; 35:126-136.
35. Rennie WJ, Dhillon SS, Conner-Spady B, et al. Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. Arthritis Rheum 2009; 61:1187-1193.
36. Baraliakos X, Landewe R, Hermann KG, et al. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 2005; 64:730-734.
37. Almodovar R, Zarco P, Collantes E, et al. Relationship between spinal mobility and disease activity, function, quality of life and radiology: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheu-matol 2009; 27:439-445.
38. Baraliakos X, Listing J, Rudwaleit M, et al. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008; 10:R104.
39. de Vlam K, Mielants H, Verstaete KL, Veys EM. The zygapophyseal joint determines morphology of the enthesophyte. J Rheumatol 2000; 27:1732-1739.
40. Marzo-Ortega H, Tanner SF, RhodesLA, et al. Magnetic resonanceimaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand J Rheumatol 2009; 38:79-83.
41. Tan YM, Ostergaard M, Doyle A, et al. MRI bone edema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radio-graphic scores for joint damage. Arthritis Res Ther 2009; 11:R2.
42. Weber U, Hodler J, Jurik AG, et al. Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis 2010; 69:648-653.
43. WeberU, Maksymowych WP, Jurik AG, et al. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum 2009; 61:893-899.
44. Mager AK, Althoff CE, Sieper J, et al. Role of whole-body magnetic resonance imaging in diagnosing early spondyloarthritis. Eur J Radiol 2009; 71:182-188.
45. Griffoul I, Giraudeau B, Mulleman D, et al. Infliximab for treating axial spon-dylarthropathy in everyday practice. Joint Bone Spine 2009; 76:39-43.
46. Taniguchi Y, Arii K, Kumon Y, et al. Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides. [Epub ahead of print]. Rheumatology (Oxford) 2010; 49:348-354.